Cleared Traditional

K925459 - GS-MODULAR (GOLD STANDARD - MODULAR) (FDA 510(k) Clearance)

Class II Anesthesiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K925459 · Warren E. Collins, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1994
Decision
463d
Days
Class 2
Risk

K925459 is an FDA 510(k) clearance for the GS-MODULAR (GOLD STANDARD - MODULAR). Classified as Spirometer, Diagnostic (product code BZG), Class II - Special Controls.

Submitted by Warren E. Collins, Inc. (Braintree, US). The FDA issued a Cleared decision on February 4, 1994 after a review of 463 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1840 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Anesthesiology submissions.

View all Warren E. Collins, Inc. devices

Submission Details

510(k) Number K925459 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 29, 1992
Decision Date February 04, 1994
Days to Decision 463 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
324d slower than avg
Panel avg: 139d · This submission: 463d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code BZG Spirometer, Diagnostic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1840
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - BZG Spirometer, Diagnostic

All 227
Devices cleared under the same product code (BZG) and FDA review panel - the closest regulatory comparables to K925459.
MESI mTABLET SPIRO
K251777 · Mesi D.O.O. · Mar 2026
TD-7301 Spirometer (TD-7301)
K241843 · Gostar Co., Ltd. · Nov 2024
Air Next (NVD-02)
K231416 · Nuvoair AB · Jan 2024
Spirobank Oxi
K230501 · Mir Medical International Research USA · Dec 2023
EasyOne Sky Spirometer
K230178 · Ndd Medizintechnik AG · Oct 2023
Alveoair Digital Spirometer
K222525 · Roundworks Technologies Private Limited · Aug 2023